Elevated CA19-9 in healthy people
- Conditions
- Not Applicable
- Registration Number
- KCT0002107
- Lead Sponsor
- Konkuk University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30000
1. People who had a health inspection at our center were surveyed. The health inspection included upper and lower endoscopy, a serum blood test (including CA19-9), abdominal sonography (or computed tomography), and a self-reporting questionnaire.
- Among the people with elevated CA 19-9 level, the subjects who had performed follow-up study for three years or more was examined. The follow-up study must include the following tests at least once; upper and lower endoscopy, abdominal CT (or sonography), and serum CA 19-9 test.
1. Subjects who had been diagnosed with pancreatic cancer, biliary cancer, stomach canncer, colon cancer
2. Subjects who had been diagnosed with GB (gall bladder) stone, biliary obstructive disease, chronic hepatitis, liver cirrhosis
3. Subjects who did not properly answer the questionnaires
4. Under the age of 17
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the incidence of eleveated CA19-9 during a medical check-up ;predisposing factors for the elevated CA 19-9 (age, gender, body mass index, cancer history, medication history etc.)
- Secondary Outcome Measures
Name Time Method the incidence and predisposing factors for occurance of related disease during the follow-up period in healthy people with elevated CA19-9